HylaPharm is led by two KU professors, Drs. Laird Forrest and Dan Aires who are developing new anticancer drugs. The company has developed a new proprietary technology using nanoparticles of hyaluronic acid and various chemotherapeutics, such as cisplatin. The advantages of their approach are increased efficacy at the site of the tumor and reduced side effects in the rest of…read more →
PRA will receive $400,000 to support the relocation to Kansas of PRA’s Research Support Coordinator training program, staff, and recruits. The company expects to create at least 70 net new jobs in Kansas in the first year, and establish a program that will recruit and train new college graduates to support clinical trials on an annual basis
SynTech Research, Inc. will receive up to $1 million (as hiring milestones are achieved). SynTech Research, Inc. is a global contract research organization (CRO) providing research, product development, and regulatory services to the agricultural, biotechnology, and food/feed industries, as well as to governmental bodies and agricultural commodity suppliers. SynTech expects to create 103 net new jobs in Kansas with an…read more →
eNovation LLC is an early-stage Kansas company focused on developing mobile health solutions for specialty physicians, initially rheumatologists.. The company will receive $73,097 to help fund product development efforts and a pilot study with 20 physicians, all aimed at validating market assumptions and preparing their system for broader launch. The company’s software platform is based on eNovation’s flagship product, iRheum,…read more →
Parnell, an Australian veterinary pharmaceutical company, will receive a $400,000 grant to support the company’s move to establish a North American headquarters in the Kansas City Animal Health Corridor. The grant will help to defray the company’s hiring during the next year of 14 new employees with an average annual wage of $150,000.
The voucher helped Immunogenetix prepare its application for a $1.5 million grant from the National Institute of Allergy and Infectious Diseases. (Approved June 6, 2012.)
CEEZAD will receive KBA funding of $868,515 to support work to develop ways to diagnose and control Schmallenberg virus, an emerging animal disease causing considerable losses in European cattle, goat and sheep herds. While Schmallenberg virus is not yet present in the United States, its recent emergence and rapid spread make it a global animal health and economic threat. CEEZAD director…read more →
HPI will receive $2.5 million to support its fiscal 2013 operations and programmatic activities. HPI is developing advanced technologies for plant gene discovery, trait validation and crop improvement in order to deliver new products and production platforms. The research team associated with the center focuses on emerging commercial opportunities for wheat and sorghum, crops in which Kansas has national leadership…read more →
Bayer Health Care, a component of the Bayer Group, an international health care and chemicals group based in Germany, has its North American headquarters in Shawnee and employs more than 450 people. A $750,000 KBA grant will provide the company an incentive to retain and expand the Shawnee facility and to hire an additional 58 new people over three years…read more →
A grant of $126,530 will partially match a National Institutes of Health grant of $253,678 won by Orbis. Orbis develops controlled-release delivery systems for the pharmaceutical, consumer product, chemical, and food and beverage industries; the NIH grant is helping the company develop a new painkiller formulation using Orbis’ proprietary technology. KBA funding will support market research and assist Orbis in defining…read more →